The involvement of the NLRP3 inflammasome in the pathogenesis of COVID-19 was postulated based on early clinical observations of the increased IL-1 signaling and high lactate dehydrogenase (LDH) levels in severe COVID-19 [1]. This evidence concerns the gene IL1B and COVID-19.